文献速递临床试验与 GCP医学教育与科研方法

PD COMM 试验:评估两种言语语言治疗对帕金森病患者有效性的随机试验过程评价方案

The PD COMM trial: a protocol for the process evaluation of a randomised trial assessing the effectiveness of two types of SLT for people with Parkinson's disease.
PubMed 文献 · Trials · 2017-08-29

PD COMM 试验是一项 III 期多中心随机对照试验,旨在评估两种言语语言治疗(SLT)方案相较于无 SLT 干预(对照组)对自报或照护者报告存在言语或嗓音问题的帕金森病患者的有效性和成本效果。本方案描述嵌入结果评价的过程评价,旨在评估 PD COMM 干预实施时发生的情况,并提供有助于解读试验结果的发现。过程评价还旨在理论模型中探究干预复杂性,了解试验干预可能如何最佳发挥作用及原因。

要点

  • PD COMM 试验为 III 期多中心随机对照试验,比较两种 SLT 方案与无 SLT 干预对照。
  • 过程评价采用混合方法设计,基于规范化过程理论和实施保真度框架。
  • 通过深度访谈、关键事件报告、基线调查、治疗记录表和家庭练习日记收集数据。

核心结论

  • 过程评价旨在评估 PD COMM 干预实施时发生的情况,并提供有助于解读试验结果的发现。
  • 过程评价还旨在理论模型中探究干预复杂性,了解试验干预可能如何最佳发挥作用及原因。

研究设计与样本

  • PD COMM 试验为 III 期多中心随机对照试验,比较两种 SLT 方案与无 SLT 干预对照。
  • 过程评价采用混合方法设计,基于规范化过程理论和实施保真度框架。
  • 通过深度访谈收集治疗师和参与者的感知与体验。
  • 收集关键事件报告、治疗师基线调查数据、治疗记录表和家庭练习日记。
  • 过程评价数据在结果评价之前独立分析,之后两组数据再合并。

局限性

  • 原文指出,迄今已发表的过程评价方案数量有限,且很少与康复治疗试验相关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The PD COMM trial is a phase III multi-centre randomised controlled trial whose aim is to evaluate the effectiveness and cost-effectiveness of two approaches to speech and language therapy (SLT) compared with no SLT intervention (control) for people with Parkinson's disease who have self-reported or carer-reported problems with their speech or voice. Our protocol describes the process evaluation embedded within the outcome evaluation whose aim is to evaluate what happened at the time of the PD COMM intervention implementation and to provide findings that will assist in the interpretation of the PD COMM trial results. Furthermore, the aim of the PD COMM process evaluation is to investigate intervention complexity within a theoretical model of how the trialled interventions might work best and why. METHODS/DESIGN: Drawing from the Normalization Process Theory and frameworks for implementation fidelity, a mixed method design will be used to address process evaluation research questions. Therapists' and participants' perceptions and experiences will be investigated via in-depth interviews. Critical incident reports, baseline survey data from therapists, treatment record forms and home practice diaries also will be collected at relevant time points throughout the running of the PD COMM trial. Process evaluation data will be analysed independently of the outcome evaluation before the two sets of data are then combined. DISCUSSION: To date, there are a limited number of published process evaluation protocols, and few are linked to trials investigating rehabilitation therapies. Providing a strong theoretical framework underpinning design choices and being tailored to meet the complex characteristics of the trialled interventions, our process evaluation has the potential to provide valuable insight into which components of the interventions being delivered in PD COMM worked best (and what did not), how they worked well and why. TRIAL REGISTRATION: ISRCTN Registry, ISRCTN12421382 . Registered on 18 April 2016.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Masterson-Algar P, Burton CR, Brady MC, et al. The PD COMM trial: a protocol for the process evaluation of a randomised trial assessing the effectiveness of two types of SLT for people with Parkinson's disease. Trials. 2017. PMID: 28851443. doi:10.1186/s13063-017-2130-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。